论文部分内容阅读
目的:观察达菲林加曼月乐联合葛根二仙汤治疗子宫腺肌病临床效果。方法:120例子宫腺肌病患者,随机分为3组,每组40例。对照组A用达菲林治疗;对照组B用达菲林联合曼月乐治疗;观察组应用达菲林加曼月乐联合葛根二仙汤治疗。连续治疗3个月经周期。结果:3组治疗3月后均闭经,但痛经程度明显减轻,子宫体积明显缩小,子宫内膜厚度变薄,与本组治疗前比较,差异有统计学意义(P<0.05);3组间比较,观察组子宫体积、子宫内膜厚度、月经量及痛经程度与对照组A、对照组B分别比较,差异无统计学意义(P>0.05);治疗6月,对照组A子宫体积增大,月经量增多,痛经程度增加,观察组与对照组A比较,差异有统计学意义(P<0.05);治疗12月,对照组A子宫体积增大,子宫内膜厚度增加,月经量增多,痛经程度增加,观察组与对照组A比较,差异有统计学意义(P<0.05)。结论:达菲林加曼月乐联合葛根二仙汤治疗子宫腺肌病疗效显著,症状改善明显,不良反应少。
Objective: To observe the clinical effect of Tamiflucan plus Mirena combined with Pueraria Decoction in the treatment of adenomyosis. Methods: 120 patients with adenomyosis were randomly divided into 3 groups, 40 cases in each group. The control group A was treated with dafenlin; the control group B was treated with dafenlin combined with Mirena; the observation group was treated with daphniromene and mireokala in combination with puerarin decoction. Continuous treatment of 3 menstrual cycles. Results: After 3 months of treatment, amenorrhoea were amenorrhea, but the degree of dysmenorrhea was significantly reduced, the uterine volume was significantly reduced, and the thickness of endometrium was thinner. There were significant differences between the three groups before treatment (P <0.05) Compared with control group A and control group B, there was no significant difference in observation group’s uterine volume, endometrial thickness, menstrual flow and dysmenorrhea (P> 0.05); in treatment group 6, the volume of uterus in control group increased , Menstruation increased, dysmenorrhea increased, the observation group compared with the control group A, the difference was statistically significant (P <0.05); treatment December, the control group A uterine volume increased, the endometrial thickness increased, menstruation increased, Dysmenorrhea increased, the observation group compared with the control group A, the difference was statistically significant (P <0.05). Conclusion: Dufayling plus Mirena combined with Pueraria Decoction treatment of adenomyosis significant effect, obvious improvement, fewer adverse reactions.